Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell Transplantation

This study has been completed.
Sponsor:
Collaborator:
Dr. Falk Pharma GmbH
Information provided by:
Rafa Laboratories
ClinicalTrials.gov Identifier:
NCT00128739
First received: August 9, 2005
Last updated: August 26, 2005
Last verified: August 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: August 2005
  Estimated Primary Completion Date: No date given